XDH and gout: Management approaches to hyperuricemia in gout include not only xanthine oxidase inhibitor (XOI) monotherapy and uricase therapy for refractory disease, but also URAT1 inhibitors (probenecid and benzbromarone) in monotherapy or in combination with XO inhibition [9].